NASDAQ:PIII P3 Health Partners (PIII) Stock Forecast, Price & News $1.38 -0.07 (-4.83%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$1.38▼$1.4650-Day Range$1.31▼$2.7952-Week Range$0.70▼$6.02Volume283,984 shsAverage Volume461,629 shsMarket Capitalization$431.50 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media P3 Health Partners MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside262.3% Upside$5.00 Price TargetShort InterestBearish8.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.30Based on 2 Articles This WeekInsider TradingAcquiring Shares$1.43 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.96) to ($0.73) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.94 out of 5 starsMedical Sector689th out of 970 stocksHealth Services Industry8th out of 14 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, P3 Health Partners has a forecasted upside of 262.3% from its current price of $1.38.Amount of Analyst CoverageP3 Health Partners has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.54% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 8.8.Change versus previous monthShort interest in P3 Health Partners has recently increased by 36.18%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 2.9 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search Interest15 people have searched for PIII on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.MarketBeat Follows9 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,427,400.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.57% of the stock of P3 Health Partners is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.96) to ($0.73) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 9.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About P3 Health Partners (NASDAQ:PIII) StockP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.Read More PIII Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesSeptember 14, 2023 | finance.yahoo.comChicago Pacific Founders UGP III, LLC Buys 270,000 Shares of P3 Health Partners IncSeptember 12, 2023 | markets.businessinsider.comBTIG Keeps Their Buy Rating on P3 Health Partners (PIII)September 29, 2023 | Tradewins (Ad)Successful Options Trading Begins With…Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month! September 10, 2023 | seekingalpha.comP3 Health Partners: Right Place, Right Time, Wrong Horse To Back?September 1, 2023 | msn.comBTIG Initiates Coverage of P3 Health Partners Inc - (PIII) with Buy RecommendationAugust 8, 2023 | finance.yahoo.comAt US$2.14, Is P3 Health Partners Inc. (NASDAQ:PIII) Worth Looking At Closely?July 28, 2023 | finance.yahoo.comP3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference CallJuly 19, 2023 | finance.yahoo.comA Look At The Fair Value Of P3 Health Partners Inc. (NASDAQ:PIII)September 29, 2023 | Tradewins (Ad)Successful Options Trading Begins With…Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month! July 10, 2023 | benzinga.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsJuly 6, 2023 | msn.comP3 Health Partners Inc - (PIII) Price Target Decreased by 15.38% to 5.61June 15, 2023 | seekingalpha.comP3 Health Partners On Solid Path To ProfitabilityJune 9, 2023 | seekingalpha.comP3 Health Partners: Just Another SPAC-Listed 'Value-Based Care' Company?June 1, 2023 | msn.comWhy Shares of P3 Health Partners Soared This WeekMay 17, 2023 | benzinga.comChief Executive Officer At This Health Care Company Buys $284K of StockMay 17, 2023 | msn.comWhy P3 Healthcare Shares Jumped WednesdayMay 16, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2023 Earnings Call TranscriptMay 10, 2023 | finance.yahoo.comP3 Health Partners Announces First-Quarter 2023 ResultsMay 3, 2023 | msn.comHere Is Why Bargain Hunters Would Love Fast-paced Mover P3 Health Partners Inc. (PIII)May 2, 2023 | finance.yahoo.comP3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference CallMay 1, 2023 | msn.comP3 Health (NASDAQ:PIII) Stock Gains on $5.6M Insider BuyApril 19, 2023 | marketwatch.comP3 Health Partners Inc. (“P3”) had Impressive 2022 Year-End Results with Capitated Revenue of approximately $1 Billion Dollars; PIIIMarch 30, 2023 | finance.yahoo.comP3 Health Partners Announces Date Change for Fourth-Quarter and Full-Year 2022 Earnings CallMarch 24, 2023 | finance.yahoo.comP3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30March 14, 2023 | finance.yahoo.comP3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 ResultsMarch 9, 2023 | finance.yahoo.comP3 Health Partners Executive to Present at Upcoming Investor ConferencesJanuary 23, 2023 | uk.news.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) drops to US$375m and insiders who purchased earlier this year lose another US$51kSee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address PIII Company Calendar Last Earnings8/07/2023Today9/29/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees600Year FoundedN/APrice Target and Rating Average Stock Price Forecast$5.00 High Stock Price Forecast$5.00 Low Stock Price Forecast$5.00 Forecasted Upside/Downside+262.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2,260.8101) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-270,130,000.00 Net Margins-10.92% Pretax Margin-59.36% Return on Equity-2,471.27% Return on Assets33.63% Debt Debt-to-Equity Ratio16.13 Current Ratio0.69 Quick Ratio0.69 Sales & Book Value Annual Sales$1.05 billion Price / Sales0.41 Cash Flow$34.50 per share Price / Cash Flow0.04 Book Value$0.15 per share Price / Book9.20Miscellaneous Outstanding Shares312,680,000Free Float259,334,000Market Cap$431.50 million OptionableNot Optionable Beta1.25 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 62)FACP, M.D., Co-Founder, CEO & Director Comp: $7.1MDr. Amir Bacchus M.B.A. (Age 58)M.D., Co-Founder, Chief Medical Officer & Director Comp: $4.3MMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExec. VP & COOMr. Devery GoodeySr. VP of TechnologyMs. Karen BlomquistVP of Investor RelationsMs. Jessica PuathasnanonChief Legal Officer, Gen. Counsel & Sec.Ms. Kassi Belz APRExec. VP of Communications, Culture & EngagementMs. Lorie Glisson CPAFlorida Market PresMr. Todd Lefkowitz MHAChief Managed Care OfficerMore ExecutivesKey CompetitorsDocGoNASDAQ:DCGOThe Pennant GroupNASDAQ:PNTGSharecareNASDAQ:SHCRTalkspaceNASDAQ:TALKInnovAgeNASDAQ:INNVView All CompetitorsInsiders & InstitutionsPacific Founders Ugp I ChicagoBought 90,000 shares on 9/13/2023Total: $238,500.00 ($2.65/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/11/2023Total: $210,600.00 ($2.34/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/7/2023Total: $185,400.00 ($2.06/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/5/2023Total: $181,800.00 ($2.02/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/1/2023Total: $186,300.00 ($2.07/share)View All Insider TransactionsView All Institutional Transactions PIII Stock - Frequently Asked Questions Should I buy or sell P3 Health Partners stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks. What is P3 Health Partners' stock price forecast for 2023? 2 brokers have issued 1-year target prices for P3 Health Partners' stock. Their PIII share price forecasts range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 262.3% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts. How have PIII shares performed in 2023? P3 Health Partners' stock was trading at $1.84 at the beginning of 2023. Since then, PIII shares have decreased by 25.0% and is now trading at $1.38. View the best growth stocks for 2023 here. Are investors shorting P3 Health Partners? P3 Health Partners saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 4,140,000 shares, an increase of 36.2% from the August 31st total of 3,040,000 shares. Based on an average daily trading volume, of 472,000 shares, the short-interest ratio is presently 8.8 days. Currently, 8.5% of the shares of the stock are short sold. View P3 Health Partners' Short Interest. When is P3 Health Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our PIII earnings forecast. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) announced its earnings results on Monday, August, 7th. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.24) by $0.15. The company earned $329.09 million during the quarter, compared to the consensus estimate of $303.30 million. P3 Health Partners had a negative net margin of 10.92% and a negative trailing twelve-month return on equity of 2,471.27%. What guidance has P3 Health Partners issued on next quarter's earnings? P3 Health Partners updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.25 billion, compared to the consensus revenue estimate of $1.24 billion. What is P3 Health Partners' stock symbol? P3 Health Partners trades on the NASDAQ under the ticker symbol "PIII." How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is P3 Health Partners' stock price today? One share of PIII stock can currently be purchased for approximately $1.38. How much money does P3 Health Partners make? P3 Health Partners (NASDAQ:PIII) has a market capitalization of $431.50 million and generates $1.05 billion in revenue each year. The company earns $-270,130,000.00 in net income (profit) each year or ($2,260.8101) on an earnings per share basis. How many employees does P3 Health Partners have? The company employs 600 workers across the globe. How can I contact P3 Health Partners? P3 Health Partners' mailing address is 2045 W GRAND AVE STUITE B, CHICAGO IL, 60612. The official website for the company is foresightacq.com. The company can be reached via phone at 702-910-3950 or via email at shalper@lifesciadvisors.com. This page (NASDAQ:PIII) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.